Key Takeaways
  • The best-supported parts are the least exotic: a fixed sleep schedule, a Mediterranean-style diet and plenty of exercise (he does about 6 hours a week)
  • Fitness is the standout: in 122,007 adults, the least fit quarter had five times the adjusted risk of death of the fittest group
  • The eating window and calorie cut are plausible but unproven for longevity
  • No trial has tested a supplement stack like his
  • He has ended two experiments: young plasma ("no benefits detected") and rapamycin, over side effects

Bryan Johnson, the tech entrepreneur behind the Blueprint brand, has made his own body a public anti-ageing project. He publishes his routine in detail on his protocol site, from bedtime to pills, and sells many of the products he uses through Blueprint (Johnson, Protocol).

Coverage tends to mock him or lionise him. Here's a plainer exercise: take each pillar as he describes it and check it against the research. Johnson himself labels the protocol "an experimental clinical research project" and says it "does not constitute medical advice". This article isn't medical advice either: talk to your doctor before changing medicines, supplements or training.

5.04×
Adjusted risk of death for the least fit quarter vs the fittest 2.3%, in 122,007 adults followed for a median 8.4 years. Observational: linked to, not proof of cause (JAMA Network Open, 2018)
Part one · The protocol

What Johnson Actually Does

From his protocol page, as of October 2026:

His page also lists hyperbaric oxygen, sauna, stem cell injections and gene therapy, which aren't graded here (see our sauna review).

The scale matters. In 2023, Bloomberg Businessweek reported that Johnson was "on track to spend at least $2 million on his body" that year, with "more than 30 doctors and health experts" monitoring him (Vance, Bloomberg Businessweek). Most readers can copy the habits, not the medical team.

Part two · Sleep

Sleep: Consistency First

Grade: Strong evidence (mostly observational)

Johnson's sleep rules are the most copyable part of the protocol, and the evidence leans his way. A 2010 meta-analysis in Sleep pooled 16 studies with 1,382,999 people and 112,566 deaths. Short sleep was linked to a 12% higher risk of death (RR 1.12) and long sleep to a 30% higher risk (RR 1.30), though definitions varied between studies (Cappuccio, Sleep 2010). The authors suggested the long-sleep link "may be explained by residual confounding and comorbidities": sleeping 9 hours or more can be a sign of illness, not a cause.

Regularity, which Johnson stresses, may matter as much as hours. In 60,977 UK Biobank participants whose sleep was measured with wrist accelerometers, people in the top four quintiles of sleep regularity had a 20% to 48% lower risk of death than the least regular fifth over a mean of about 6.3 years. The authors concluded that "sleep regularity was a stronger predictor of all-cause mortality than sleep duration" (Windred, Sleep 2023).

Both are observational, so they show association, not proof. But a consistent schedule costs nothing. You don't need an 8:30 pm bedtime, just one you can keep (more in our sleep and longevity guide).

Part three · Exercise

Exercise: The Pillar With the Most Weight

Grade: Strong evidence (mortality data observational)

The CDC says adults need 150 minutes of moderate activity a week, or 75 minutes of vigorous activity, plus at least 2 days of muscle-strengthening (CDC). Johnson does the 150 and the 75, plus three strength sessions: roughly double the aerobic minimum.

Fitness is one of the strongest predictors of survival we have. In a 2018 study in JAMA Network Open, 122,007 adults (mean age 53) had a treadmill test and were followed for a median 8.4 years. Risk-adjusted mortality fell with every step up in fitness. Compared with elite performers, the least fit quarter had an adjusted hazard ratio of 5.04, and even "high" performers had more risk than elite ones (Mandsager, JAMA Netw Open 2018). The authors found "no observed upper limit of benefit".

Figure 1 · Mandsager et al., 2018

Share who died during follow-up, by fitness level

Low bottom 25% · 29,181 23.7% Below average 25th–49th · 27,172 10.6% Above average 50th–74th · 31,897 7.3% High 75th–97.6th · 30,187 4.7% Elite top 2.3% · 3,570 2.6%

Mandsager K, et al. JAMA Network Open 2018. Crude deaths divided by group size over a median 8.4 years; categories are age- and sex-matched percentiles of treadmill performance. These raw shares aren't adjusted; after adjustment, the low group's risk was 5.04 times the elite group's. Observational: linked to survival, not proof of cause.

Strength training adds to that. A 2022 meta-analysis of 16 prospective cohort studies in the British Journal of Sports Medicine linked muscle-strengthening activities to a 15% lower risk of death from all causes (relative risk 0.85), with the biggest reduction at about 30 to 60 minutes a week. The authors said the effect of higher volumes "is unclear" (Momma, Br J Sports Med 2022). Combining strength and aerobic work was linked to lower risk than doing neither.

This is the pillar most worth copying, even if you stop well short of 6 hours a week.

Part four · Food

Diet: Good Food, an Early Cut-Off and Fewer Calories

What he eats

Grade: Strong evidence for the food pattern

Minus the branded powders, Johnson's plate resembles a Mediterranean diet, which has trial evidence behind it. In PREDIMED, 7,447 people in Spain at high cardiovascular risk were assigned to a Mediterranean diet with extra virgin olive oil, one with nuts, or a reduced-fat control diet. Over a median 4.8 years, major cardiovascular events (heart attack, stroke or cardiovascular death) were lower in the olive oil group (hazard ratio 0.69) and the nuts group (0.72) than in controls (Estruch, NEJM 2018, via ACC). These are revised 2018 estimates: the authors withdrew their 2013 report because not all participants had been randomised as planned. More in our olive oil guide.

The 10% calorie cut

Grade: Plausible but unproven for longevity

No trial has measured whether modest calorie restriction lengthens human life. The main human test is CALERIE: 218 healthy adults under 50 were asked to cut calories by 25% for two years. They managed about 12% on average, and kept off about 10% of their weight, 71% of it fat. Cholesterol, blood pressure, blood sugar and a marker of inflammation improved (Duke Health, on Kraus, Lancet Diabetes Endocrinol 2019). Better risk factors are encouraging, but they aren't a longer life.

Stopping at noon

Grade: Plausible but unproven

Johnson eats within roughly a six-and-a-half-hour morning window. Time-restricted eating has been tested mainly for weight loss, and the results are mixed:

Figure 2 · Time-restricted eating trials

Does a shorter eating window add anything?

TrialWho and how longWindowResult
Lowe, JAMA Intern Med 2020116 adults with overweight or obesity analysed, 12 weeks12 pm–8 pm, no calorie target−0.94 kg vs −0.68 kg; difference not significant lean mass fell in the eating-window group
Liu, NEJM 2022139 adults with obesity, 12 months, calories cut in both groups8 am–4 pm−8.0 kg vs −6.3 kg; difference not significant
Jamshed, JAMA Intern Med 202290 adults with obesity, 14 weeks, calories cut in both groups7 am–3 pm vs 12+ hours−6.3 kg vs −4.0 kg; 2.3 kg more lost diastolic blood pressure 4 mm Hg lower

Lowe DA, et al. 2020; Liu D, et al. 2022; Jamshed H, et al. 2022. None of these trials measured lifespan, and none studied lean, very active people like Johnson.

In TREAT, the eating-window group also lost lean mass, with a significant between-group difference in arm and leg lean mass among participants who had body-composition scans (Lowe 2020). The 12-month trial concluded that time-restricted eating "was not more beneficial with regard to reduction in body weight" (Liu 2022). The trial closest to Johnson's early window did find extra weight loss (Jamshed 2022). Our fasting timeline covers what happens as the hours pass.

Part five · Pills

Supplements and Drugs: Untested as a Stack

Grade: Plausible but unproven

Here the evidence thins. We found no trial testing a combination like Johnson's against outcomes such as heart attacks, cancer or death, and large single-supplement trials have mostly disappointed:

That doesn't make every item useless: creatine plus resistance training gives a small but reliable strength boost (see our creatine guide). But "each ingredient has a study" isn't "the stack works". Note too that Johnson's page points readers to the "Blueprint stack", which his company sells.

His prescription list is a separate matter. These are prescription medicines, and taking any of them for longevity is a decision for you and a doctor who knows your history, not something to copy from a website.

Part six · Testing

Measurement: Useful Data, One Person's Results

Grade: Mixed. Standard checks: sensible. Whole-body MRI: no good evidence

Johnson reports striking numbers: blood pressure "lower than 90% of 18-year-olds", and "eight months of 100% perfect sleep" on his wearable. Regular blood tests and check-ups can catch real problems (see our blood tests after 40 guide).

Two cautions. First, one person's biomarkers are not evidence for anyone else. He does dozens of things at once, so nobody can say which habit moved which number, or whether better markers mean a longer life. His own disclaimer says claims about measuring or reversing biological age "are preliminary" (and our biological age test review explains why). Second, more scanning isn't automatically better. The American College of Radiology says there is "no documented evidence that total body screening is cost-efficient or effective in prolonging life" for people without symptoms, and warns of "unnecessary follow-up testing and procedures" (ACR, 2023).

Part seven · Experiments he ended

Young Plasma and Rapamycin: What He Stopped

Grade: No good evidence / possible harm

To his credit, Johnson publishes the experiments that didn't work.

Young plasma. In 2023 he did a widely covered plasma exchange involving his then-17-year-old son and 70-year-old father. In July 2023 he posted: "Discontinuing therapy: completed 6, 1L young plasma exchanges" and "Evaluated biomarkers from biofluids, devices and imaging, no benefits detected." He added that young plasma exchange "may be beneficial for biologically older populations or certain conditions" and that it "does not in my case stack benefit on top of my existing interventions" (Fortune, 2023). In 2019 the FDA warned: "There is no proven clinical benefit of infusion of plasma from young donors to cure, mitigate, treat, or prevent these conditions", conditions it said range from "normal aging and memory loss" to dementia and Parkinson's disease, and warned of "infectious, allergic, respiratory and cardiovascular risks, among others" (FDA statement; STAT, 2019).

Rapamycin. Johnson began taking rapamycin, a transplant drug that extends lifespan in mice, in 2019. In September 2024 he ended it, saying the benefits didn't outweigh the drawbacks. He reported intermittent skin infections, high glucose, abnormal blood lipids and a higher resting heart rate, and wrote that "since dosage adjustments had no effect, we decided to discontinue it entirely" (Johnson, 2025; Scientific American/Nature, 2026). Whether rapamycin extends human life hasn't been established. We go through the evidence in rapamycin and longevity.

The impressionAn extreme protocol, so the extreme parts must be doing the work.
What the research showsThe best evidence supports the ordinary pillars: sleep, food, fitness. The most exotic parts are the least tested, and two of them Johnson has already dropped.
Figure 3 · The scorecard

Bryan Johnson's protocol, graded

PillarWhat he doesGradeKey evidence
Exercise6 h a week: 150 min Zone 2, 75 min vigorous, 3 strength sessionsStrong evidence122,007 adults: low vs elite fitness, adjusted HR 5.04 Mandsager 2018; Momma 2022
SleepBed 8:30 pm, up about 4:30–5 am, fixed schedule, wind-downStrong evidence observationalRegular sleepers: 20–48% lower mortality Windred 2023; Cappuccio 2010
Food patternVegetables, legumes, berries, nuts, extra virgin olive oilStrong evidencePREDIMED: major CV events HR 0.69 with olive oil Estruch 2018
Calorie cut2,250 kcal, about 10% below RDAPlausible but unprovenCALERIE: about 12% cut improved risk factors over 2 years no lifespan data
Eating windowLast meal around noonPlausible but unprovenMixed weight-loss trials Lowe 2020; Liu 2022; Jamshed 2022
SupplementsDaily Blueprint stack, creatine, fibre powdersPlausible but unprovenNo trial of the stack; VITAL omega-3 null on main outcomes Manson 2019; USPSTF 2022
TestingProtocol checklist: bloods every 3–6 months; annual full-body MRI if over 40 or high riskMixedACR: no evidence total body screening prolongs life
Young plasma6 exchanges; stopped 2023No good evidence / possible harm"No benefits detected" (Johnson); FDA 2019 warning
RapamycinTaken from 2019; stopped September 2024No good evidence / possible harmSide effects he reported; human lifespan benefit not shown

Grades are The Longevity Den's judgment of the published evidence for the general practice, not of Johnson's personal results. Protocol details from protocol.bryanjohnson.com, October 2026.

Part eight · What to do

What You Can Reasonably Borrow

Frequently Asked Questions

What is Bryan Johnson's Blueprint protocol?
The anti-ageing regimen Bryan Johnson publishes online: an 8:30 pm bedtime, 2,250 calories a day with the last meal around noon, 6 hours of exercise a week, supplements, prescription drugs and frequent testing. He calls it an experimental clinical research project, not medical advice.
Which parts of Bryan Johnson's protocol have the strongest evidence?
The unglamorous ones: regular sleep, a Mediterranean-style diet and plenty of exercise. In 122,007 adults, the least fit quarter had five times the adjusted risk of death of the fittest group.
Does stopping eating at noon help you live longer?
There is no evidence on lifespan. Weight-loss trials are mixed: trials of 116 and 139 adults found no significant extra weight loss, while a 14-week trial of 90 adults eating from 7 am to 3 pm found 2.3 kg more.
Did young plasma or rapamycin work for Bryan Johnson?
By his own account, no. In July 2023 he said six young plasma exchanges showed no benefits. In September 2024 he stopped rapamycin, citing side effects including skin infections and high glucose. The FDA says young donor plasma has no proven clinical benefit.
Should I copy Bryan Johnson's supplement stack?
No trial has tested a stack like his, and big single-supplement trials often disappoint: omega-3 didn't reduce major cardiovascular events or cancer in 25,871 adults. Talk to your doctor first.
The Bottom Line

The boring parts work. The exotic parts are untested.

At its foundations, Bryan Johnson's protocol is advice any good doctor would recognise: train often, sleep on a schedule, eat mostly plants with olive oil and nuts. The calorie cut and early eating window are unproven for longevity, the stack is untested, and he has dropped two of his boldest experiments.

His results are one person's. Borrow the habits, skip pills you don't need, and talk to your doctor before anything with a prescription attached.

Sources

  1. Johnson B. Bryan Johnson's Protocol. protocol.bryanjohnson.com, accessed 22 October 2026.
  2. Vance A. How to Be 18 Years Old Again for Only $2 Million a Year. Bloomberg Businessweek, 2023 (via inkl).
  3. Cappuccio FP, D'Elia L, Strazzullo P, Miller MA. Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep 2010;33(5):585–592.
  4. Windred DP, Burns AC, Lane JM, et al. Sleep regularity is a stronger predictor of mortality risk than sleep duration: a prospective cohort study. Sleep 2023 (doi:10.1093/sleep/zsad253).
  5. Centers for Disease Control and Prevention. Physical activity guidelines for adults.
  6. Mandsager K, Harb S, Cremer P, et al. Association of cardiorespiratory fitness with long-term mortality among adults undergoing exercise treadmill testing. JAMA Network Open 2018;1(6):e183605.
  7. Momma H, Kawakami R, Honda T, Sawada SS. Muscle-strengthening activities are associated with lower risk and mortality in major non-communicable diseases: a systematic review and meta-analysis of cohort studies. British Journal of Sports Medicine 2022;56(13):755–763.
  8. Estruch R, Ros E, Salas-Salvadó J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. New England Journal of Medicine 2018;378(25) (doi:10.1056/NEJMoa1800389). As summarised by the American College of Cardiology.
  9. Kraus WE, Bhapkar M, Huffman KM, et al. 2 years of calorie restriction and cardiometabolic risk (CALERIE): exploratory outcomes of a multicentre, phase 2, randomised controlled trial. Lancet Diabetes & Endocrinology 2019;7(9):673–683 (doi:10.1016/S2213-8587(19)30151-2). As reported by Duke Health (24 September 2019).
  10. Lowe DA, Wu N, Rohdin-Bibby L, et al. Effects of time-restricted eating on weight loss and other metabolic parameters in women and men with overweight and obesity: the TREAT randomized clinical trial. JAMA Internal Medicine 2020;180(11):1491.
  11. Liu D, Huang Y, Huang C, et al. Calorie restriction with or without time-restricted eating in weight loss. New England Journal of Medicine 2022;386(16):1495–1504.
  12. Jamshed H, Steger FL, Bryan DR, et al. Effectiveness of early time-restricted eating for weight loss, fat loss, and cardiometabolic health in adults with obesity: a randomized clinical trial. JAMA Internal Medicine 2022;182(9):953.
  13. Manson JE, Cook NR, Lee IM, et al. Marine n−3 fatty acids and prevention of cardiovascular disease and cancer. New England Journal of Medicine 2019;380(1):23–32. As summarised by NIHR Evidence.
  14. US Preventive Services Task Force. Vitamin, mineral, and multivitamin supplementation to prevent cardiovascular disease and cancer. JAMA 2022;327(23):2326. As reported by the American College of Cardiology (21 June 2022).
  15. American College of Radiology. ACR statement on screening total body MRI. 17 April 2023.
  16. Mikhail A. Tech CEO Bryan Johnson admits he saw 'no benefits' after controversially injecting his son's plasma into his body to reverse his biological age. Fortune, 8 July 2023.
  17. US Food and Drug Administration. Statement from FDA Commissioner Scott Gottlieb, M.D., and Director of FDA's Center for Biologics Evaluation and Research Peter Marks, M.D., Ph.D., cautioning consumers against receiving young donor plasma infusions. 19 February 2019. Text as reproduced by American Pharmaceutical Review; reported by STAT.
  18. Stokel-Walker C. Tech titans are hacking their bodies for a longer life: is there science behind their methods? Nature 2026;654:589–591. Republished by Scientific American as Silicon Valley's longevity biohackers are engaged in a dangerous experiment.
  19. Johnson B. I stopped taking rapamycin. Blueprint, 25 January 2025.